Sera Prognostics, Inc.

SERA
NASDAQMedical Devices

-87.6%

since IPO

IPO Price

$16.00

Current Price

$1.98

Return

-87.6%

Market Cap

$75.6M

IPO Date

Jul 15, 2021

Lockup End

Jan 11, 2022

Lockup Status

Lockup expired 1569days ago

Price Performance

Stock price vs IPO price over time (sample data)

Stock Price
IPO Price
Lockup End

Performance Summary

First Day
N/A
1 Month
N/A
3 Months
N/A
6 Months
N/A
1 Year
N/A
Since IPO
-87.6%

Sera Prognostics, Inc. (SERA) — IPO Analysis

By Kian O Connor | Updated 4/29/2026

Company Overview

Sera Prognostics, Inc. (ticker: SERA) specializes in innovation initiatives while maintaining strategic capabilities in quality assurance, positioning itself within the Medical Devices sector through innovation focus and premium quality offerings. The company has developed its operations around customer satisfaction, creating market differentiation through specialized expertise and transaction-based fee structure that supports sustainable growth and customer relationship development. The company completed its public offering on 2021-07-15, accessing capital markets during digital transformation trends within the Medical Devices landscape. The IPO timing reflected the company's strategic positioning and growth trajectory, with market reception emphasizing management's execution capabilities and the company's approach to innovation initiatives as key value creation drivers in an evolving competitive environment. Post-IPO trading performance has demonstrated challenging market conditions requiring strategic adjustments and operational focus to demonstrate value creation potential. Market assessment focuses on the company's innovation focus and strategic emphasis on quality assurance as indicators of long-term competitive positioning within the Medical Devices sector, with investors evaluating operational execution and market opportunity capture relative to industry development trends. The lockup period expires February 08, 2022, providing market insights into management and early investor confidence in strategic direction and competitive positioning. Given the company's focus on innovation initiatives and emphasis on customer satisfaction, insider trading decisions will likely reflect assessments of execution progress, competitive dynamics, and growth opportunity realization within the evolving Medical Devices market landscape.

Performance Overview

Since going public at $16.00 per share on Jul 15, 2021, Sera Prognostics, Inc. shares have declined 87.6%, disappointing investors who participated in the IPO. The stock currently trades at $1.98, giving the company a market capitalization of $75.6M.

Lockup Expiration

The lockup period for Sera Prognostics, Inc. expired 1569 days ago on Jan 11, 2022. Insiders and early investors are now free to sell their pre-IPO shares. The post-lockup trading period is often volatile as the market absorbs any additional supply from insider selling.

Industry Context

Sera Prognostics, Inc. operates in the Medical Devices sector, which has seen varied IPO activity in recent years. The company is headquartered in the United States and is classified under SIC code . Understanding the competitive landscape and sector dynamics is essential for evaluating the long-term prospects of any newly public company in this space. Investors should consider broader market conditions, sector-specific trends, and company fundamentals when assessing SERA as an investment.

Trading History

Sera Prognostics, Inc. is actively trading in the public markets with a current share price of $1.98. The company went public at $16.00 per share, representing a decline of 87.6% from the initial offering price. With a current market capitalization of $75.6M, Sera Prognostics, Inc. continues to establish its presence as a publicly traded entity in the Medical Devices.

Important Disclaimer

This analysis of Sera Prognostics, Inc. (SERA) is provided for informational purposes only and should not be construed as investment advice. All data is sourced from SEC EDGAR filings and public market feeds. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making investment decisions. IPOLockup.io is an independent research platform with no financial interest in any of the companies covered.

Insider Selling Activity

Estimated insider trading activity around lockup expiry period (sample data)

2
Pre-Expiry Average
Minimal
95
Expiry Day
Very High
55
Post-Expiry (30d)
High

Activity Heatmap

60 days before/after lockup expiry
Intensity Scale:
Minimal
Low
Moderate
High
Very High
Lockup Expiry

About This Data

This heatmap shows estimated insider selling activity based on typical patterns around lockup expiry periods. Actual data would be derived from SEC Form 4 filings. Higher intensity indicates more insider transactions, which may correlate with increased selling pressure and potential stock price volatility.

Related IPOs

TickerCompanyIndustryIPO DateIPO PriceCurrentReturn
LMRILumexa Imaging Holdings, Inc.Medical DevicesDec 11, 2025$18.50$9.34-49.5%
POASPhaos Technology Holdings (Cayman) LimitedMedical DevicesNov 13, 2025$4.00$2.14-46.5%
PMIPicard Medical, Inc.Medical DevicesAug 29, 2025$4.00$0.45-88.8%
CVCapsoVision, Inc.Medical DevicesJul 2, 2025$5.00$6.78+35.6%
BBNXBeta Bionics, Inc.Medical DevicesJan 30, 2025$17.00$10.08-40.7%
CBLLCeriBell, Inc.Medical DevicesOct 11, 2024$17.00$20.80+22.4%
ITOCiTonic Holdings Ltd.Medical DevicesSep 5, 2024N/A$0.40N/A
WOKWORK Medical Technology Group LTDMedical DevicesAug 23, 2024$4.00$1.20-70.0%

Related IPO Analysis

KO
By • Founder & Data Analyst